DE60130684T2 - Substituierte pyrrolidine als ccr-3-rezeptorantagonisten - Google Patents

Substituierte pyrrolidine als ccr-3-rezeptorantagonisten Download PDF

Info

Publication number
DE60130684T2
DE60130684T2 DE60130684T DE60130684T DE60130684T2 DE 60130684 T2 DE60130684 T2 DE 60130684T2 DE 60130684 T DE60130684 T DE 60130684T DE 60130684 T DE60130684 T DE 60130684T DE 60130684 T2 DE60130684 T2 DE 60130684T2
Authority
DE
Germany
Prior art keywords
compound
alkyl
formula
alk
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60130684T
Other languages
German (de)
English (en)
Other versions
DE60130684D1 (de
Inventor
Denis John Mountain View Kertesz
Michael Garret San Franscisco ROEPEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60130684D1 publication Critical patent/DE60130684D1/de
Application granted granted Critical
Publication of DE60130684T2 publication Critical patent/DE60130684T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60130684T 2000-12-19 2001-12-13 Substituierte pyrrolidine als ccr-3-rezeptorantagonisten Expired - Fee Related DE60130684T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25658500P 2000-12-19 2000-12-19
US256585P 2000-12-19
PCT/EP2001/014670 WO2002050064A1 (en) 2000-12-19 2001-12-13 Substituted pyrrolidines as ccr-3 receptor antagonists

Publications (2)

Publication Number Publication Date
DE60130684D1 DE60130684D1 (de) 2007-11-08
DE60130684T2 true DE60130684T2 (de) 2008-08-14

Family

ID=22972794

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130684T Expired - Fee Related DE60130684T2 (de) 2000-12-19 2001-12-13 Substituierte pyrrolidine als ccr-3-rezeptorantagonisten

Country Status (15)

Country Link
US (2) US6552028B2 (enExample)
EP (1) EP1358181B1 (enExample)
JP (1) JP2004519443A (enExample)
KR (1) KR20030061455A (enExample)
CN (1) CN1239498C (enExample)
AR (1) AR035519A1 (enExample)
AT (1) ATE374198T1 (enExample)
AU (1) AU2002216107A1 (enExample)
BR (1) BR0116352A (enExample)
CA (1) CA2431767A1 (enExample)
DE (1) DE60130684T2 (enExample)
ES (1) ES2292530T3 (enExample)
MX (1) MXPA03005581A (enExample)
WO (1) WO2002050064A1 (enExample)
ZA (1) ZA200304530B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1871222A (zh) * 2003-10-24 2006-11-29 霍夫曼-拉罗奇有限公司 Ccr3受体拮抗剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
KR20010081034A (ko) * 1998-11-20 2001-08-25 프리돌린 클라우스너, 롤란드 비. 보레르 피페리딘 씨씨알-3 수용체 길항제
JP3593037B2 (ja) 1998-11-20 2004-11-24 エフ．ホフマン−ラ ロシュ アーゲー ピロリジン誘導体ｃｃｒ−３受容体アンタゴニスト
CA2347909A1 (en) 1998-12-18 2000-06-22 Joseph B. Santella, Iii N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ATE302005T1 (de) 1998-12-18 2005-09-15 Bristol Myers Squibb Pharma Co N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
AU2057200A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2056700A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
CA2347912A1 (en) 1998-12-18 2000-06-22 Soo S. Ko Heterocyclic piperidines as modulators of chemokine receptor activity
EP1156807A4 (en) 1998-12-18 2002-04-03 Du Pont Pharm Co N-UREIDOALKYL-PIPERIDINES FOR USE AS MODULATORS OF THE ACTIVITY OF CHIMIOKIN RECEPTORS
AU3126700A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
BR0116352A (pt) 2003-12-02
ES2292530T3 (es) 2008-03-16
US6552028B2 (en) 2003-04-22
MXPA03005581A (es) 2003-10-06
ZA200304530B (en) 2004-09-10
AR035519A1 (es) 2004-06-02
ATE374198T1 (de) 2007-10-15
US20020198255A1 (en) 2002-12-26
CN1481379A (zh) 2004-03-10
EP1358181B1 (en) 2007-09-26
DE60130684D1 (de) 2007-11-08
CA2431767A1 (en) 2002-06-27
WO2002050064A1 (en) 2002-06-27
KR20030061455A (ko) 2003-07-18
JP2004519443A (ja) 2004-07-02
EP1358181A1 (en) 2003-11-05
US20030199532A1 (en) 2003-10-23
CN1239498C (zh) 2006-02-01
AU2002216107A1 (en) 2002-07-01

Similar Documents

Publication Publication Date Title
AU763960B2 (en) Pyrrolidine derivatives-CCR-3 receptor antagonists
DE69921351T2 (de) 4-Aroyl-Piperidin-CCR-3 Rezeptorantagonisten III
DE69833073T2 (de) CCR-3-Rezeptor-Antagonisten
DE60005485T2 (de) Indolderivate und ihre verwendung als mcp-1 rezeptor antagonisten
DE69008012T2 (de) 4-Fluorbenzolderivate, Herstellungsverfahren und diese enthaltende pharmazeutische Zusammensetzungen.
DE60015296T2 (de) Indolderivate und ihre verwendung als mcp-1 rezeptor antagonisten
US6342509B1 (en) Piperidine quaternary salts- CCR- 3 receptor antagonists
DE69108461T2 (de) 1-Indolylalkyl-4-(alkoxy-pyrimidinyl)piperazine.
DE69813605T2 (de) Benzofuranderivate
DE60221275T2 (de) Piperazin-derivate zur verwendung als ccr-3 rezeptor antagonisten zur behandlung von asthma
US6984643B2 (en) 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists
DE60222015T2 (de) Ccr-3-rezeptorantagonisten vii
US6552028B2 (en) 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists
EP1220845B1 (de) Arylsulfonamid-substituierte benzimidazolderivate ihre verwendung als tryptase-inhibitoren
DE69610851T2 (de) Disubstituierte piperidine-derivate
DD270909A5 (de) Verfahren zur herstellung von 2,1-benzothiazepin-2,2-dioxid-5-carbonsaeurederivaten

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee